POPULARITY
Categories
164 episodes with american society
136 episodes with american society
134 episodes with american society
65 episodes with american society
70 episodes with american society
73 episodes with american society
75 episodes with american society
63 episodes with american society
107 episodes with american society
30 episodes with american society
37 episodes with american society
32 episodes with american society
36 episodes with american society
32 episodes with american society
31 episodes with american society
20 episodes with american society
24 episodes with american society
26 episodes with american society
12 episodes with american society
17 episodes with american society
21 episodes with american society
15 episodes with american society
23 episodes with american society
32 episodes with american society
63 episodes with american society
22 episodes with american society
10 episodes with american society
17 episodes with american society
23 episodes with american society
10 episodes with american society
22 episodes with american society
15 episodes with american society
15 episodes with american society
20 episodes with american society
15 episodes with american society
21 episodes with american society
27 episodes with american society
18 episodes with american society
35 episodes with american society
7 episodes with american society
12 episodes with american society
14 episodes with american society
11 episodes with american society
13 episodes with american society
8 episodes with american society
10 episodes with american society
18 episodes with american society
19 episodes with american society
11 episodes with american society
11 episodes with american society
25 episodes with american society
19 episodes with american society
13 episodes with american society
23 episodes with american society
Dr. Timothy Larsen writes about serious, energetic faith in the places other historians assume the faith cannot really be. A Victorian Christian fantasist. A Westminster canon who quietly set aside biblical authority. And, in his newest and most acclaimed book, seventeen Anglican chaplains who came out of the trenches of World War I as radicals. Tim is McManis Professor of Christian Thought at Wheaton College and the 2025 president of the American Society of Church History, and this hour is us moving through three of his books at once. The Fires of Moloch takes its title from H. G. Wells's line describing Britain sending its sons into the fires of a false god during the Passchendaele Offensive. George MacDonald in the Age of Miracles takes the mid-nineteenth-century Scottish theological turn from the Age of Atonement to the Age of the Incarnation and shows what happens when a rigorously Calvinist minister-turned-fantasy-writer decides doubt is the door in, and therefore the door out, of a mature faith. Every Leaf, Line, and Letter returns to Tim's PhD supervisor David Bebbington's famous quadrilateral for defining evangelicalism and asks what it takes to keep that word doing honest work now that polls will code Muslim Trump voters as evangelical. Come for Anglo-Catholic sacramental confession as battle-tested ministry. Stay for the George MacDonald grandmother who burned her son's violin because he enjoyed music too much. You can WATCH the conversation on YouTube Dr. Timothy Larsen is McManis Professor of Christian Thought and Professor of History at Wheaton College, an Honorary Fellow of the School of Divinity at the University of Edinburgh, and an Honorary Research Fellow at the University of Wales Trinity Saint David. He is a Fellow of the Royal Historical Society and a Fellow of the Royal Anthropological Institute. He has been a Visiting Fellow at Trinity College, Cambridge, All Souls College, Oxford, and Christ Church, Oxford. In 2025 he served as President of the American Society of Church History. He has authored or edited more than twenty books. Books at the center of this conversation: The Fires of Moloch: Anglican Clergymen in the Furnace of World War One; George MacDonald in the Age of Miracles: Incarnation, Doubt, and Reenchantment ; and Every Leaf, Line, and Letter: Evangelicals and the Bible from the 1730s to the Present. JOIN OUR OPEN ONLINE CLASS: The Empire Christ Couldn't Keep Ever notice how Christian nationalism gets talked about like it's some bizarre new glitch in the faith? It isn't — it's a 2,000-year-old arrangement wearing new clothes, and once you see how the pattern works, you can also spot the Christ who keeps slipping free of it. Join theologian Joerg Rieger and Tripp Fuller for The Christ Empire Couldn't Keep, a free six-week online class tracing the holy alliances, imperial creeds, and stubborn resistance that have shaped Christianity from Paul to the present. You'll get six lectures from Joerg, six live Q&As, weekly readings from his book Christ and Empire, and a community of fellow troublemakers thinking it through together. It's free to join, every session is recorded, and it kicks off Thursday, August 27. Grab your spot at HomebrewedClasses.com. This podcast is a Homebrewed Christianity production. Follow the Homebrewed Christianity, Theology Nerd Throwdown, & The Rise of Bonhoeffer podcasts for more theological goodness for your earbuds. Join over 75,000 other people by joining our Substack - Process This! Get instant access to over 50 classes at www.TheologyClass.com Follow the podcast, drop a review, send feedback/questions or become a member of the HBC Community. Learn more about your ad choices. Visit megaphone.fm/adchoices
John Galbraith, Holden Mrizek, and Liz Eroshenko join Jim Cudahy to discuss soil judging and the recent International Soil Judging Contest. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to John, you can find him here: ttcf@vt.edu Resources Transcripts: https://www.rev.com/app/transcript/NmE1OGZlZDQ5NzFjZDJlNjJkY2M1YmExOFIxSG5oQUxZd3c1/o/VEMwOTUyNjM2ODE5 Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.
Keeping the "LIVE" in Alive! In this Wellness Wednesday Feature Interview , I got a sneak peek at one of the world's biggest nutrition gatherings—Nutrition 2026, hosted by the American Society for Nutrition. Researchers from around the globe gather to reveal the latest discoveries about how food affects our health. My guest was Dr. Diane Stadler, professor of medicine and director of graduate programs in Human Nutrition at Oregon Health & Science University. One of the first things we agreed on? Food really is medicine. I laughed remembering my Italian grandmothers feeding us what we used to call "peasant food"—beans, greens, fresh vegetables and simple meals from the garden. Funny how those same foods are now considered some of the healthiest things you can eat! As I joked on the show: "Our ancestors already knew what to do... somewhere along the way we forgot." Dr. Stadler explained that convenience and processed foods gradually replaced home cooking over the past several decades—and while they've made life easier, they've also made healthy eating more complicated. A Few Big Takeaways Whole foods still win. Whenever possible, choose foods closer to their natural form instead of heavily processed versions. GLP-1 medications work—but nutrition still matters. As these weight-loss drugs become more common, researchers are emphasizing the importance of getting enough protein, vitamins, minerals, and exercise to help preserve muscle while losing weight. Food safety matters too. With recent produce recalls making headlines, Dr. Stadler recommends buying whole vegetables when possible, washing them well, and preparing them yourself. And my favorite surprise? The humble red pepper! When I asked Diane why she always adds one to her salad, she smiled and said: "Red peppers are one of the highest sources of vitamin A and vitamin C... they supercharge my day." By the end of the interview I had officially declared: "I'll always use a red pepper from now on because of Diane!" Debservation: Sometimes the newest science simply reminds us of what our grandparents and ancestors practiced all along. Eat more real food. Move your body. Don't overcomplicate it. That's the kind of wellness advice that never goes out of style. This Week's Keeping the LIVE in Alive! Challenge Add one extra colorful vegetable to your plate every day this week. Maybe it'll be a red pepper... like mine. :-) Hope you enjoy our conversation. Best! Debbie
Today I am honored to speak with Elizabeth Hinton and Elsa Julien Lora about their new book, Harm and Punishment: Incarcerated Writers on Violence and the US Prison. Along with two research assistants, Lora and Hinton pored over hundreds of essays by prisoners, found in the American Prison Writing Archive. They then selected and organized the essays found in this volume, offering illuminating introductions to each section.Our discussion moves through many topics—the brutal, dehumanizing, and punitive nature of the prison system, the damage it does to lives both inside and outside prison, and the ways prisoners find to survive and offer each other support, despite being pitted against each other. At base, we consider how we, as a society, are “addicted to violence,” and why and how it is crucial to understand that violence can only produce more violence. These essays organically blend personal observations and stories with a deep understanding of the broad, systemic nature of violence.Elizabeth Hinton is one of the nation's leading experts on the roots of mass incarceration and enduring inequality in the United States. The Class of 1954 Professor of History, Black Studies, and Law at Yale University, Hinton serves as the founding director of the Justice for Everybody Movement J4EM, a university-based center focused on promoting public safety through education, research, and coalition-building. At Harvard, she is the founding co-director (with Brandon M. Terry) of the Hutchins Center's Institute on Policing, Incarceration, and Public Safety. Hinton's groundbreaking books—From the War on Poverty to the War on Crime and America on Fire—were each named New York Times Notable Books and have become essential texts in policy and social justice circles. A sought-after public intellectual, Hinton's commentary appears in The New York Times, The Washington Post, The Atlantic, New York Magazine, The Los Angeles Times and beyond. Her research has been supported by the Carnegie Corporation and the Guggenheim, Mellon, and Ford Foundations. Hinton served on the National Academies of Sciences Committee on Reducing Racial Inequalities in the Criminal Justice System and in 2022 was elected to the American Philosophical Society as one of the youngest members in its history. At J4EM, Hinton is building the infrastructure for a more just and robust democracy—where education is not a privilege, but a cornerstone of public safety.Elsa Julien Lora is a U.S. historian and interdisciplinary scholar whose research focuses on the history of American prisons and the texture and intimacy of family life. A Postdoctoral Research Fellow at the Columbia University Society of Fellows, Elsa is at work on her book, Life in Prison: An Intimate History of American Punishment. Her research has been supported by the Mellon Foundation, the American Council of Learned Societies, the Institute for Citizens and Scholars, and the American Society for Legal History. Elsa's writing about race, justice, and family has appeared in the Virginia Quarterly Review, Aperture, and Public Books, and she is currently producing a documentary about her grandmother, boundary-breaking modern dancer Mary Hinkson. She holds a PhD in African and African American Studies from Harvard University and a JD from Yale Law School.
In this episode of FP&A Unlocked, hosts Paul Barnhurst and Glenn Snyder sit down with Josette Ferrer to discuss one of the most overlooked skills in finance: networking. While many finance professionals focus on technical expertise, Josette explains why building genuine relationships is essential for career growth, leadership development, mentorship, and long-term success. Josette Ferrer is the Founder and Managing Director of Clairent Advisors, a valuation and business advisory firm specializing in business and intellectual property valuations. She also serves as President of the San Francisco Bay Area chapter of Financial Executives International (FEI) and is actively involved with organizations including How Women Lead, ProVisors, the American Society of Appraisers, and several executive leadership communities.Expect to Learn:Why networking should start long before you need your next opportunityHow to choose the right networking organizations for your career goalsSimple strategies introverts can use to build meaningful professional relationshipsWhy mentoring and networking naturally go hand in handHere are a few relevant quotes from the episode:"Networking isn't transactional, it's about giving, helping, and building relationships." - Josette Ferrer"You don't need a title to add value; small gestures can create lasting connections." - Josette FerrerNetworking is a crucial skill for FP&A professionals, enabling stronger relationships, mentorship, and career growth. Starting early and engaging genuinely helps build trust and opportunities over time. Remember, networking is about giving and adding value, not just seeking benefits for yourself.Follow Josette Ferrer:LinkedIn: https://www.linkedin.com/in/josetteferrer/Follow Glenn Snyder:LinkedIn: https://www.linkedin.com/in/glennsnyder/Earn Your CPE CreditFor CPE credit, please go to earmarkcpe.com, listen to the episode, download the app, answer a few questions, and earn your CPE certification. To earn education credits for the FPAC Certificate, take the quiz on earmark and contact Paul Barnhurst for further details.In Today's Episode:[00:00] – Trailer[04:22] – What Great FP&A Looks Like[12:36] – Choosing the Right Networking Group[21:23] – Why You Should Start Networking Early[27:39] – Building and Maintaining Your Professional Network[33:18] – Networking Strategies for Introverts[41:21] – The Power of Mentorship[52:05] – Final Networking Advice for Finance Professionals
Is medication replacing one addiction with another? Does harm reduction encourage drug use? Why do addiction professionals sometimes disagree about the best path to recovery? In this episode, Joseph and Paula tackle some of the most debated topics in addiction treatment. Together, they explore how our understanding of addiction has evolved over time, why controversy continues to shape the field, and what current research tells us about evidence-based care.You'll learn about the history of addiction treatment, the role of medications for opioid use disorder (MOUD), and the principles behind harm reduction all through the lens of science, compassion, and real-world counseling experience. Along the way, Joseph and Paula introduce their Controversy Meter, separating myths from evidence while encouraging thoughtful conversation rather than heated debate. Whether you're a professional, someone in recovery, a family member, or simply curious about addiction treatment, this episode offers practical insights and a balanced perspective on some of the field's most important and misunderstood topics.Questions? If you have questions, you would like Joseph and Paula to address during an upcoming episode of Questions for Counselors, feel free to reach out through the website at www.lifelivedbetter.net or email them directly at Info@lifelivedbetter.net You can find information about this and other episodes on the website: www.lifelivedbetter.net. Just a reminder - Anything shared during this and all other episodes is based on personal experiences and opinions. It is not to be viewed as professional counseling or advice - it is solely our opinion. Information shared does not represent our employers or profession. We would love for you to rate our show and tell others about us. And remember, Knowledge leads to a Life Lived Better. Resources used to create the episodes on this topic: American Society of Addiction Medicine. (2020). The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update. Journal of Addiction Medicine, 14(2S), 1–91.National Institute on Drug Abuse. (2024). Medications to treat opioid use disorder. https://nida.nih.govSubstance Abuse and Mental Health Services Administration. (2024). TIP 63: Medications for Opioid Use Disorder (Updated). https://store.samhsa.govSubstance Abuse and Mental Health Services Administration. (2023). Harm Reduction Framework. https://www.samhsa.govResource for NaloxoneDrugs.com for Narcan Emergency Kit resources Next Distro - This national Naloxone program collaborates with nationwide US harm reduction programs. On their website you will find: Links to distribution programs throughout the United StatesPharmacies that carry NaloxoneAn extensive Resource LibraryAccess to Naloxone supplies for free in Texas, contact Naloxone Texas
Roses have a reputation for being high-maintenance, but the best rose breeders are chasing a different future: roses that bloom for months, shrug off disease, and succeed for everyday gardeners. We sit down with Dr. David Zlesak, a master rosarian and rose breeder, to unpack how roses went from ancient treasures traded across regions to the modern plants you see at big box stores and independent nurseries.We dig into the deep history of cultivated roses, including how genetics is rewriting origin stories and how repeat-bloom traits from historic Chinese roses helped shape today's garden varieties. Then we zoom into what buyers want now, from cut-rose goals like longer shelf life, fewer thorns, and more fragrance, to shifting tastes in flower form influenced by everything from rose shows to English-style, old-fashioned blooms.The conversation turns practical and science-forward: black spot disease resistance, why multiple races make durability hard, and how stacking resistance genes and developing useful genetic markers can speed up breeding progress. We also explore environmental stress, including heat tolerance and winter hardiness, and how the American Rose Trials for Sustainability (ARTS) tests roses regionally to identify truly tough, low-input performers. Finally, David shares how the rose business has changed, why Knock Out roses reset the market's expectations, and the career mindset that keeps him moving: ask what if, focus on market-limiting traits, and build a community of collaborators.If you love gardening, plant breeding, or sustainable horticulture, subscribe for more conversations like this, share the episode with a fellow rose grower, and leave a review so more listeners can find Plants, People, Science.Read more from David Zlesak - Plant Science Students' Thinking Styles and Multiple Intelligences Based on Major, Gender, and CourseThe Effects of Short-term Drying on Seed Germination in RosaNorthern Accents® ‘Lena', ‘Ole', ‘Sigrid', and ‘Sven': Four Cold-hardy Polyantha Rose Cultivars from the University of Minnesota Woody Landscape Plant Breeding ProgramSend us Fan MailLearn more about the American Society for Horticultural Science (ASHS) at https://ashs.org/.HortTechnology, HortScience and the Journal of the American Society for Horticultural Science are all open-access and peer-reviewed journals, published by the American Society of Horticultural Science (ASHS). Find them at journals.ashs.org.Consider becoming an ASHS member at https://ashs.org/page/Becomeamember!You can also find the official webpage for Plants, People, Science at ashs.org/plantspeoplesciencepodcast, and we encourage you to send us feedback or suggestions at https://ashs.org/webinarpodcastsuggestion. Podcast transcripts are available at https://plantspeoplescience.buzzsprout.com.On LinkedIn find Sam Humphrey at linkedin.com/in/samson-humphrey. Curt Rom is at https://www.linkedin.com/in/curt-rom-611085134/. Lena Wilson is at https://www.linkedin.com/in/lena-wilson-2531a5141/.Thank you for listening!...
Gregor und Marcus glauben, ein heimliches Wirtschaftswunder-Gerät gefunden zu haben: die Klimaanlage. Ist kühle Luft womöglich ein uralter Business-Case und die Grundlage für den Erfolg ganzer Staaten?**********HörtippFacts & Feelings - Wie verlieren wir die Angst vorm Investieren?**********In dieser Folge:3:11 - Luft kühlen - früher und heute11:40 - Singapur - Wirtschaftlicher Aufstieg dank Klimaanlage?18:10 - Zu wenige Klimaanlagen in Deutschland?20:54 - Fazit / Wahres für Bares23:42 - Hörtipp: Facts & Feelings - Wie verlieren wir die Angst vorm Investieren?**********An dieser Folge waren beteiligt: Autoren: Gregor Lischka und Marcus Wolf Faktencheck: Merle Körber und Kathrin Krautwasser Produktion: Uwe Breunig Redaktion: Michael Böddeker **********Die Quellen zur Folge:Allianz Research / Allianz Trade. "Too Hot to Grow – The Economic Costs of Extreme Heat." Allianz Trade, 28. Mai 2026. American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE). "A History of Comfort Cooling Using Ice." Atlanta: ASHRAE.Glaeser, Edward L., and Kristina Tobio. "The Rise of the Sunbelt." NBER Working Paper 2007-04. Cambridge, MA: Harvard University and National Bureau of Economic Research, 2007.International Energy Agency (IEA). The Future of Cooling: Opportunities for Energy-Efficient Air Conditioning. Paris: IEA, 2018. International Labour Organization. Report on Heat Stress and Labour Productivity, 2019. Cited in Sustainable Energy for All, "The Productivity Penalty of Failing to Deliver Sustainable Cooling". Alle Quellen findet ihr hier.**********Unsere Empfehlungen:CNA Insider: Why This Albanian Moved To Singapore To Fix Air Conditioners – Singapore Hour **********Weitere Beiträge zum Thema:Waschmaschine vs. Internet: Die Frage nach der wichtigsten Innovation der Wirtschaftsgeschichte**********Habt ihr auch manchmal einen WTF-Moment, wenn es um Wirtschaft und Finanzen geht? Wir freuen uns über eure Themenvorschläge und Feedback an whatthewirtschaft@deutschlandfunknova.de.**********Den Artikel zum Stück findet ihr hier.**********Ihr könnt uns auch auf diesen Kanälen folgen: TikTok und Instagram .
Copyright © 2026 by the American Society of Anesthesiologists. This podcast was translated and recorded by Cactus Communications with the Society's permission. This translation has been generated using AI-powered tools and refined through human review to ensure the quality and accuracy of the transcript. However, it does not constitute a guarantee of the completeness or absolute accuracy of the content. Transcript
Copyright © 2026 by the American Society of Anesthesiologists. This podcast was translated and recorded by Cactus Communications with the Society's permission. This translation has been generated using AI-powered tools and refined through human review to ensure the quality and accuracy of the transcript. However, it does not constitute a guarantee of the completeness or absolute accuracy of the content. Transcript
Copyright © 2026 by the American Society of Anesthesiologists. This podcast was translated and recorded by Cactus Communications with the Society's permission. This translation has been generated using AI-powered tools and refined through human review to ensure the quality and accuracy of the transcript. However, it does not constitute a guarantee of the completeness or absolute accuracy of the content. Transcript
Copyright © 2026 by the American Society of Anesthesiologists. This podcast was translated and recorded by Cactus Communications with the Society's permission. This translation has been generated using AI-powered tools and refined through human review to ensure the quality and accuracy of the transcript. However, it does not constitute a guarantee of the completeness or absolute accuracy of the content. Transcript
Can you be too old to conceive? What does it really mean when celebrities have babies over 50? And when fertility treatments like IVF, donor eggs, frozen eggs, and embryo transfer make pregnancy possible after menopause, how do we decide when it is safe, ethical, and medically appropriate? In this episode of Brave & Curious, Dr. Lora Shahine explores one of the biggest and most emotionally loaded questions in reproductive medicine: when is it too late to have a baby? Using the latest 2025 American Society for Reproductive Medicine guidelines as a starting point, Dr. Shahine breaks down advanced reproductive age, age-related infertility, IVF success with own eggs versus donor eggs, pregnancy after menopause, and the very real health risks that can come with pregnancy over 45 or 50. She also looks at paternal age, sperm health, and why age matters for both partners when building a family. Listeners will understand that there is no one-size-fits-all answer—only thoughtful counseling, informed consent, and brave conversations about the risks, benefits, and possibilities of family building at an advanced reproductive age. In this episode you'll hear: [00:56] Age & Fertility overview [01:41] Record-breaking pregnancy stories [02:37] Why does it get more difficult to get pregnant as we get older? [07:52] Health risks of pregnancy [09:15] Men: reproductive age and health of pregnancy [10:07] Ethical considerations [11:13] 2025 ASRM guidelines [13:42] Next steps Dr. Shahine's Weekly Newsletter on Fertility News and Recommendations Follow @drlorashahine Instagram | YouTube | Tiktok | Her Books Join the Learn at Pinnacle app to earn FREE CE Credit for listening to this episode! This episode was produced by Audiotocracy Podcast Production.
From Season 5 – We talked to Maggie Olson, founder of Nova Chief of Staff, about the qualities and skills needed for an admin or EA to become a Chief of Staff. Recorded at APC 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.
Recorded live from Beaches Turks & Caicos, this episode of the Sandals Palmcast invites Zane Kerby, President and CEO of the American Society of Travel Advisors. While at Beaches Turks and Caicos'newest village providing a firsthand look at how family travel preferences are evolving, Randi and Zane dive into the biggest trends shaping the industry today, from the rise of AI and the influence of social media to the growing demand for meaningful family vacations and memory-making experiences. Zane shares insights into what travel advisors across North America are seeing right now, why advisors are more valuable than ever, and what distinguishes a good advisor from a truly exceptional one. The discussion covers the evolving interests and preferences shaping today's travel landscape, provides insights for aspiring travel advisors, and highlights what continues to make the Caribbean a top destination.
I had a patient walk into my office recently looking frustrated. She sat down, crossed her arms, and said, "Dr. Shelly, my medication has stopped working. I lost 32 pounds, but for the last six weeks my weight hasn't budged. Am I immune to this medication?" If you've looked at the scale lately and wondered the same thing, this episode is for you. In this episode, I'm walking you through the seven most common reasons weight loss plateaus happen, from still being on a starting dose to hidden medical conditions like thyroid issues or PCOS that can quietly work against you. I'll also break down why protein intake and resistance training matter more than most people realize once a GLP-1 medication kicks in. But here's what matters most: a plateau doesn't mean your medication has failed. Your body is incredibly smart, and adapting is exactly what it's designed to do. You'll learn exactly what's happening biologically during a stall, and the five practical steps to get your progress moving again. Episode Highlights: Why plateaus are a normal, expected part of every weight loss journey, not a sign of failure Why your starting dose may not be your effective dose yet How low protein intake quietly stalls progress and costs you muscle Why resistance training protects the muscle mass your metabolism depends on How untreated sleep issues like sleep apnea can sabotage results The hidden medical conditions, from thyroid issues to PCOS, that can slow weight loss Why hitting a plateau might actually mean you've already succeeded Five practical steps to get moving again when progress stalls Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
Fear of the False: Forensic Science and the Law of Crime in Colonial South Asia (Cornell University Press, 2026) uncovers colonial South Asia's critical role in the development of forensic science. Around 1900, the government of British India created a web of institutions for the scientific detection of crime. Driven by anxieties about "native mendacity," newly minted forensic analysts focused on uncovering faked evidence planted by South Asians. These experts, joining toxicologists known as "chemical examiners," were supposed to extract objective, scientific truth in the service of British justice. But in trying to counteract the presumed tendency of colonized peoples to lie, the system enabled widespread misconduct by state experts, increasing the risk of wrongful convictions of South Asian defendants. Through scrupulously documented legal cases, Mitra Sharafi reveals that colonial dynamics put special pressure on the relationship between truth and justice. Examining falsity on both sides of the law through the use of testing to (mis)identify poisons, blood, and spermatozoa, as well as debates over adversarialism and inquisitorialism in the colonial courtroom, Fear of the False explores advances in forensic science and shortcuts in criminal procedure against the backdrop of colonial mistrust. Thanks to generous funding from the University of Wisconsin Law School, the ebook editions of this book are available as open access volumes through the Cornell Open initiative. Mitra Sharafi is a legal historian whose research focuses on South Asia. She is the Evjue-Bascom Professor of Law at University of Wisconsin-Madison and currently serves as the president of the American Society for Legal History. She has been the host of the South Asian Legal History Resources website since 2010. Saumya Dadoo is a PhD candidate at Columbia University's Department of Middle East, South Asian, and African Studies (MESAAS). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network
Fear of the False: Forensic Science and the Law of Crime in Colonial South Asia (Cornell University Press, 2026) uncovers colonial South Asia's critical role in the development of forensic science. Around 1900, the government of British India created a web of institutions for the scientific detection of crime. Driven by anxieties about "native mendacity," newly minted forensic analysts focused on uncovering faked evidence planted by South Asians. These experts, joining toxicologists known as "chemical examiners," were supposed to extract objective, scientific truth in the service of British justice. But in trying to counteract the presumed tendency of colonized peoples to lie, the system enabled widespread misconduct by state experts, increasing the risk of wrongful convictions of South Asian defendants. Through scrupulously documented legal cases, Mitra Sharafi reveals that colonial dynamics put special pressure on the relationship between truth and justice. Examining falsity on both sides of the law through the use of testing to (mis)identify poisons, blood, and spermatozoa, as well as debates over adversarialism and inquisitorialism in the colonial courtroom, Fear of the False explores advances in forensic science and shortcuts in criminal procedure against the backdrop of colonial mistrust. Thanks to generous funding from the University of Wisconsin Law School, the ebook editions of this book are available as open access volumes through the Cornell Open initiative. Mitra Sharafi is a legal historian whose research focuses on South Asia. She is the Evjue-Bascom Professor of Law at University of Wisconsin-Madison and currently serves as the president of the American Society for Legal History. She has been the host of the South Asian Legal History Resources website since 2010. Saumya Dadoo is a PhD candidate at Columbia University's Department of Middle East, South Asian, and African Studies (MESAAS). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/south-asian-studies
Fear of the False: Forensic Science and the Law of Crime in Colonial South Asia (Cornell University Press, 2026) uncovers colonial South Asia's critical role in the development of forensic science. Around 1900, the government of British India created a web of institutions for the scientific detection of crime. Driven by anxieties about "native mendacity," newly minted forensic analysts focused on uncovering faked evidence planted by South Asians. These experts, joining toxicologists known as "chemical examiners," were supposed to extract objective, scientific truth in the service of British justice. But in trying to counteract the presumed tendency of colonized peoples to lie, the system enabled widespread misconduct by state experts, increasing the risk of wrongful convictions of South Asian defendants. Through scrupulously documented legal cases, Mitra Sharafi reveals that colonial dynamics put special pressure on the relationship between truth and justice. Examining falsity on both sides of the law through the use of testing to (mis)identify poisons, blood, and spermatozoa, as well as debates over adversarialism and inquisitorialism in the colonial courtroom, Fear of the False explores advances in forensic science and shortcuts in criminal procedure against the backdrop of colonial mistrust. Thanks to generous funding from the University of Wisconsin Law School, the ebook editions of this book are available as open access volumes through the Cornell Open initiative. Mitra Sharafi is a legal historian whose research focuses on South Asia. She is the Evjue-Bascom Professor of Law at University of Wisconsin-Madison and currently serves as the president of the American Society for Legal History. She has been the host of the South Asian Legal History Resources website since 2010. Saumya Dadoo is a PhD candidate at Columbia University's Department of Middle East, South Asian, and African Studies (MESAAS). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science-technology-and-society
Fear of the False: Forensic Science and the Law of Crime in Colonial South Asia (Cornell University Press, 2026) uncovers colonial South Asia's critical role in the development of forensic science. Around 1900, the government of British India created a web of institutions for the scientific detection of crime. Driven by anxieties about "native mendacity," newly minted forensic analysts focused on uncovering faked evidence planted by South Asians. These experts, joining toxicologists known as "chemical examiners," were supposed to extract objective, scientific truth in the service of British justice. But in trying to counteract the presumed tendency of colonized peoples to lie, the system enabled widespread misconduct by state experts, increasing the risk of wrongful convictions of South Asian defendants. Through scrupulously documented legal cases, Mitra Sharafi reveals that colonial dynamics put special pressure on the relationship between truth and justice. Examining falsity on both sides of the law through the use of testing to (mis)identify poisons, blood, and spermatozoa, as well as debates over adversarialism and inquisitorialism in the colonial courtroom, Fear of the False explores advances in forensic science and shortcuts in criminal procedure against the backdrop of colonial mistrust. Thanks to generous funding from the University of Wisconsin Law School, the ebook editions of this book are available as open access volumes through the Cornell Open initiative. Mitra Sharafi is a legal historian whose research focuses on South Asia. She is the Evjue-Bascom Professor of Law at University of Wisconsin-Madison and currently serves as the president of the American Society for Legal History. She has been the host of the South Asian Legal History Resources website since 2010. Saumya Dadoo is a PhD candidate at Columbia University's Department of Middle East, South Asian, and African Studies (MESAAS). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/law
Fear of the False: Forensic Science and the Law of Crime in Colonial South Asia (Cornell University Press, 2026) uncovers colonial South Asia's critical role in the development of forensic science. Around 1900, the government of British India created a web of institutions for the scientific detection of crime. Driven by anxieties about "native mendacity," newly minted forensic analysts focused on uncovering faked evidence planted by South Asians. These experts, joining toxicologists known as "chemical examiners," were supposed to extract objective, scientific truth in the service of British justice. But in trying to counteract the presumed tendency of colonized peoples to lie, the system enabled widespread misconduct by state experts, increasing the risk of wrongful convictions of South Asian defendants. Through scrupulously documented legal cases, Mitra Sharafi reveals that colonial dynamics put special pressure on the relationship between truth and justice. Examining falsity on both sides of the law through the use of testing to (mis)identify poisons, blood, and spermatozoa, as well as debates over adversarialism and inquisitorialism in the colonial courtroom, Fear of the False explores advances in forensic science and shortcuts in criminal procedure against the backdrop of colonial mistrust. Thanks to generous funding from the University of Wisconsin Law School, the ebook editions of this book are available as open access volumes through the Cornell Open initiative. Mitra Sharafi is a legal historian whose research focuses on South Asia. She is the Evjue-Bascom Professor of Law at University of Wisconsin-Madison and currently serves as the president of the American Society for Legal History. She has been the host of the South Asian Legal History Resources website since 2010. Saumya Dadoo is a PhD candidate at Columbia University's Department of Middle East, South Asian, and African Studies (MESAAS). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/british-studies
Fear of the False: Forensic Science and the Law of Crime in Colonial South Asia (Cornell University Press, 2026) uncovers colonial South Asia's critical role in the development of forensic science. Around 1900, the government of British India created a web of institutions for the scientific detection of crime. Driven by anxieties about "native mendacity," newly minted forensic analysts focused on uncovering faked evidence planted by South Asians. These experts, joining toxicologists known as "chemical examiners," were supposed to extract objective, scientific truth in the service of British justice. But in trying to counteract the presumed tendency of colonized peoples to lie, the system enabled widespread misconduct by state experts, increasing the risk of wrongful convictions of South Asian defendants. Through scrupulously documented legal cases, Mitra Sharafi reveals that colonial dynamics put special pressure on the relationship between truth and justice. Examining falsity on both sides of the law through the use of testing to (mis)identify poisons, blood, and spermatozoa, as well as debates over adversarialism and inquisitorialism in the colonial courtroom, Fear of the False explores advances in forensic science and shortcuts in criminal procedure against the backdrop of colonial mistrust. Thanks to generous funding from the University of Wisconsin Law School, the ebook editions of this book are available as open access volumes through the Cornell Open initiative. Mitra Sharafi is a legal historian whose research focuses on South Asia. She is the Evjue-Bascom Professor of Law at University of Wisconsin-Madison and currently serves as the president of the American Society for Legal History. She has been the host of the South Asian Legal History Resources website since 2010. Saumya Dadoo is a PhD candidate at Columbia University's Department of Middle East, South Asian, and African Studies (MESAAS). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/book-of-the-day
You are being marketed to. Aggressively. And the people doing it know exactly when to come for you: when your skin starts changing, when the products that worked for years suddenly stop working, when you catch yourself in a mirror and think, what is happening to my face. That moment of vulnerability is worth billions of dollars to the aesthetics industry. And most of what they're selling you is not backed by clinical evidence. Here's what's actually happening. When estrogen drops during menopause, your skin loses collagen at a rate of about 2.1% per year, and in the first five years after menopause alone, you can lose up to 30% of your skin's collagen. No serum fixes that. No $300 peptide cream fixes that. In this episode, I'm getting you straight answers. I brought in the person I would send my own clients to, and he's going to walk you through every major in-office skin treatment being marketed to midlife women right now. Lasers, peels, injectables, microneedling, red light, and exosomes, all of it. What actually works, what's overhyped, what's a waste of money, and what to ask before you hand over your credit card to anyone. My guest is Dr. Omer Ibrahim, MD, a board-certified, fellowship-trained dermatologist. His fellowship in cosmetic, laser, and dermatologic surgery was completed with clinical faculty from Harvard, Yale, and Brown. He did his residency at Cleveland Clinic, where he served as Chief Resident. He's a published researcher, adjunct faculty at Cleveland Clinic, and a member of the American Society for Laser Medicine and Surgery. He specializes in every major laser procedure and the full range of injectables, and he has no financial stake in selling you any particular device or product. There is no room for bias here. You deserve an action plan that actually works. Find Dr. Ibrahim here: Instagram: @chicagoskindoc and @Salmalita_Cosmetics Stay Connected with JFW: Book your 60-minute Menopause Care Consultation: https://www.jillfooswellness.com/menopause-care-consult-page Follow on Instagram: @jillfooswellness Follow on Facebook: @jillfooswellness Follow on YouTube: @jillfooswellness Grab discounts on my favorite menopause wellness products: https://www.jillfooswellness.com/health-products Enjoy 20% savings and free shipping at Fullscript for your favorite supplements by leading brands: https://us.fullscript.com/welcome/jillfooswellness/store-start Subscribe to the JFW newsletter at www.jillfooswellness.com and receive your FREE Guide on How To Create Your Menopause Health Equation Ebook. Schedule your free 15-minute consultation here: https://calendly.com/jillfooswellness/15-minute-zoom-consultations If you're a Chicago-area midlife woman, check out the Chicago Menopause Collective, a nonprofit dedicated to navigating menopause locally with experts: https://chicagomenopausecollective.org
CardioNerds (Drs. Apoorva Gangavelli, Jenna Skowronski, and Hannah Every) discuss the continuum of prevention and heart failure with Drs. Anu Lala and Martha Gulati. Grounded in a clinical case of a 55-year-old woman with uncontrolled hypertension, type 2 diabetes, and obesity who is on the trajectory toward heart failure, this episode unpacks a paradigm-shifting framework from a joint HFSA/ASPC Scientific Statement. The discussion explores how prevention should not be siloed from heart failure management but rather integrated across a patient’s lifespan—from primary prevention in at-risk individuals, to secondary prevention in those with established heart failure, to tertiary prevention in patients with advanced therapies such as LVADs and heart transplantation. The experts highlight the importance of aggressive risk factor management, biomarker-guided screening, the AHA’s Life’s Essential 8, and the need for multidisciplinary collaboration and systems-level change to shift heart failure care from reactive to proactive. Audio editing for this episode was performed by CardioNerds Intern, Dr. Julia Marques Fernandes. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Systemic inflammatory diseases are associated with an elevated CVD risk that has significant implications for early detection, risk Heart failure prevention is a continuum, not a checkpoint. Prevention applies at every stage—from at-risk (Stage A) through advanced/post-transplant care—and every clinical encounter is an opportunity to intervene. The AHA’s Life’s Essential 8 (diet, physical activity, nicotine exposure, sleep, BMI, blood lipids, blood glucose, blood pressure) forms the foundation at every stage. Hypertension carries the highest population-attributable risk for heart failure of any modifiable risk factor. In the Framingham Heart Study, 91% of patients with newly diagnosed HF had pre-existing hypertension. The SPRINT trial demonstrated a 38% reduction in HF incidence with intensive blood pressure targets (30 ng/L or NT-proBNP >125 ng/L) identify individuals at heightened risk for progression to symptomatic HF. The ACC/AHA/HFSA guidelines give a Class IIa recommendation for natriuretic peptide screening in at-risk patients. Urine albumin-to-creatinine ratio (UACR) is an underutilized screening tool that provides additional insight into CKM risk. The heart failure label does not close the prevention window—it accentuates it. Secondary prevention through GDMT optimization (quadruple therapy in HFrEF) and continued risk factor management remains critical. Tertiary prevention extends to post-LVAD and post-transplant patients, where hypertension, diabetes, obesity, and CKD management remain essential to long-term outcomes. Show notes For a comprehensive review, please review the full HFSA/ASPC Joint Scientific Statement: Lala A, Beavers C, Blumer V, et al. The Continuum of Prevention and Heart Failure in Cardiovascular Medicine. J Card Fail. 2026;32:75-105. doi:10.1016/j.cardfail.2025.06.013 1. What is the “continuum of prevention” framework, and how does it differ from traditional approaches to heart failure prevention? Historically, prevention and heart failure management have been treated as separate disciplines—primary prevention handled by preventive cardiologists and treatment managed by heart failure specialists. This joint HFSA/ASPC Scientific Statement reframes prevention as a dynamic, continuous process that spans a patient’s entire lifespan, regardless of HF stage or ejection fraction. The framework maps onto the ACC/AHA HF staging system: Primary prevention targets Stage A (“at risk”) and Stage B (“pre-HF”) patients to reduce the burden of incident HF. Secondary prevention targets Stage C (symptomatic) and Stage D (advanced) patients to reduce the impact of established HF through GDMT optimization and ongoing risk factor management. Tertiary prevention encompasses risk factor management in patients with LVADs or heart transplants—populations where hypertension, diabetes, and obesity still drive outcomes. The Central Figure of the statement illustrates that Life’s Essential 8 (blood pressure and lipid control, diabetes management, exercise, sleep, smoking cessation, weight management, and diet/nutrition counseling) forms the foundation at every stage, with pharmacologic and device-based therapies layered on top as disease progresses (Figure) 2. How do traditional risk factors drive heart failure, and what should clinicians prioritize? Hypertension carries the greatest population-attributable risk for HF. In the Framingham Heart Study (N=5,143), HTN was associated with a 2- to 3-fold increased risk of HF, with a population-attributable risk of 39% in men and 59% in women. The SPRINT trial showed a 38% reduction in HF incidence and 25% reduction in the primary composite outcome with intensive BP targets (30 ng/L or NT-proBNP >125 ng/L) are associated with heightened risk for progression to symptomatic HF. In the ARIC study, incorporating NT-proBNP reclassified 20% of older adults without HF into Stage B. Factors that affect interpretation include age, sex, obesity (lower values), and CKD (higher values). High-sensitivity cardiac troponin (hs-cTn): Concentrations above the 99th percentile are now included in the definition of Stage B HF. Troponin testing may complement natriuretic peptides, particularly when BNP/NT-proBNP values are ambiguous. Risk scores: The PCP-HF equation predicts 10-year HF risk using traditional risk factors plus QRS duration. The AHA PREVENT score incorporates HF risk calculation and includes markers of kidney function (albuminuria, eGFR), though it may underestimate risk in men and Black adults. The CKM syndrome staging framework (Stages 0–4) provides a holistic approach to assessing systemic cardiovascular-kidney-metabolic risk. 4. What are the key nontraditional risk factors and cross-cutting themes in heart failure prevention? Genetics: Pathogenic cardiomyopathy variants exist in ~1 in 200 individuals in the general population. The HFSA and ACMG recommend cascade testing to identify at-risk family members. Polygenic risk scores for dilated cardiomyopathy show a 3.8-fold risk for DCM in the top 10th percentile compared with the median. Sex-specific considerations: Women have 2.8 times the odds of developing HFpEF, while men have similarly increased odds of HFrEF. A complete obstetric/gynecologic history is essential—preeclampsia is associated with a 4-fold increased risk of HF. Peripartum cardiomyopathy requires intentional screening in high-risk populations. Cardiotoxic exposures: Clinicians should be aware of medications that cause direct myocardial toxicity (e.g., anthracyclines, trastuzumab, tyrosine kinase inhibitors). A team-based approach with pharmacists can help optimize medication selection and risk factor modification. Social determinants of health: Environmental exposures (air pollution, arsenic, lead, cadmium), food insecurity, financial instability, and limited healthcare access contribute to HF risk and progression. Equity-focused, risk-based prevention strategies are needed. Psychological health: Depression is common in HF and independently associated with worse outcomes. Screening with brief questionnaires (e.g., PHQ-2) is recommended. Meditation, spirituality, and holistic wellness approaches remain underutilized. 5. What systems-level and policy changes are needed to move the needle on heart failure prevention? Multidisciplinary HF prevention clinics that bring together preventive cardiologists, HF specialists, endocrinologists, nephrologists, dietitians, pharmacists, exercise physiologists, and genetic counselors are advocated by the statement. EHR-embedded risk stratification could proactively flag patients on a trajectory toward HF—analogous to sepsis alerts or fall risk flags—enabling earlier intervention, particularly for patients who may not reach a cardiologist. Cardiac rehabilitation remains underutilized, particularly in HFrEF (Class 2b recommendation) and HFpEF (not yet covered by Medicare). The HF-ACTION trial showed quality-of-life benefits, and the REHAB-HF trial showed particular benefit in older patients with HFpEF. Policy priorities include expanding insurance coverage for preventive screening and novel therapies (SGLT2i, GLP-1 RAs, nsMRAs), reducing clinical inertia through team-based care models with closer follow-up intervals, and ensuring equitable access to evidence-based therapies across diverse populations. Digital health and AI hold promise for personalized risk prediction, remote monitoring (e.g., wearable devices, implantable PA pressure monitors), and virtual cardiac rehabilitation to overcome access barriers. Figure Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. J Card Fail. 2026;32(1):75-105. doi:10.1016/j.cardfail.2025.06.013) References Key references are bolded. Lala A, Beavers C, Blumer V, et al. The continuum of prevention and heart failure in cardiovascular medicine: a joint scientific statement from the Heart Failure Society of America and the American Society for Preventive Cardiology. J Card Fail. 2026;32(1):75-105. doi:10.1016/j.cardfail.2025.06.013 Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.0000000000001063 Lloyd-Jones DM, Allen NB, Anderson CAM, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18-e43. doi:10.1161/CIR.0000000000001078 SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-2116. doi:10.1056/NEJMoa1511939 Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557-1562. doi:10.1001/jama.1996.03530440037034 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997. doi:10.1001/jama.288.23.2981 Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153. doi:10.1056/NEJM200001203420301 Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128. doi:10.1056/NEJMoa1504720 Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa2107038 Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-1098. doi:10.1056/NEJMoa2206286 Filippatos G, Anker SD, Agarwal R, et al. Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial. Circulation. 2022;145(6):437-447. doi:10.1161/CIRCULATIONAHA.121.057983 Solomon SD, McMurray JJV, Vaduganathan M, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2024;391(16):1475-1485. doi:10.1056/NEJMoa2407107 Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563 Deanfield J, Verma S, Scirica BM, et al. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet. 2024;404(10454):773-786. doi:10.1016/S0140-6736(24)01498-3 Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389(12):1069-1084. doi:10.1056/NEJMoa2306963 Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636-1664. doi:10.1161/CIR.0000000000001175 Khan SS, Matsushita K, Sang Y, et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation. 2024;149(6):430-449. doi:10.1161/CIRCULATIONAHA.123.067626 Khan SS, Ning H, Shah SJ, et al. 10-year risk equations for incident heart failure in the general population. J Am Coll Cardiol. 2019;73(19):2388-2397. doi:10.1016/j.jacc.2019.02.057 Bozkurt B, Fonarow GC, Goldberg LR, et al. Cardiac rehabilitation for patients with heart failure: JACC expert panel. J Am Coll Cardiol. 2021;77(11):1454-1469. doi:10.1016/j.jacc.2021.01.030 Packer M. Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. Circulation. 2018;137(15):1614-1631. doi:10.1161/CIRCULATIONAHA.117.032474 Lala A, Tayal U, Hamo CE, et al. Sex differences in heart failure. J Card Fail. 2022;28(3):477-498. doi:10.1016/j.cardfail.2021.10.006 Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure. Eur J Heart Fail. 2021;23(3):352-380. doi:10.1002/ejhf.2115 Hershberger RE, Givertz MM, Ho CY, et al. Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail. 2018;24(5):281-302. doi:10.1016/j.cardfail.2018.03.004 Levine GN, Cohen BE, Commodore-Mensah Y, et al. Psychological health, well-being, and the mind-heart-body connection: a scientific statement from the American Heart Association. Circulation. 2021;143(10):e763-e783. doi:10.1161/CIR.0000000000000947 Ezekowitz JA, Colin-Ramirez E, Ross H, et al. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet. 2022;399(10333):1391-1400. doi:10.1016/S0140-6736(22)00369-5
S5 Ep19: Limitless Leaders Edition | Leading Teams, Big & SmallHosted by: Donna Tepper, MDGuest Speakers: Amy Moore, MD; Andrea Pusic, MD; Vedra Augenstein, MD About Enhance Your PracticeEnhance Your Practice is the official practice management podcast from the American Society of Plastic Surgeons (ASPS), featuring conversations with leaders in plastic surgery on practice management, leadership, innovation, and professional development. Each episode delivers practical insights to help plastic surgeons build successful practices and thrive throughout their careers.Explore more educational resources from ASPS at plasticsurgery.org.
Episodio 1138 de Contralínea En Vivo conducido por Aníbal García y Pablo Rojas: -La estrategia de la derecha para desestabilizar México; caso American Society- Transmisión 23 de julio de 2026 CONTRALÍNEA EN VIVO se transmite de lunes a viernes a partir de las 10:00hrs (hora del centro de México) a través de Facebook live, YouTube y Telegram. La MESA DE ECONOMÍA POLÍTICA se trasmite todos los lunes a partir de las 14:00hrs. Nuestro programa de análisis, AMÉRICA INSUMISA, se trasmite los martes a partir de las 14hrs. Los viernes no te pierdas GENERACIÓN DE CRISTAL, a partir de las 14:00hrs. Estamos en Facebook, YouTube, Twitter, TikTok, Instagram, Whatsapp y Telegram como Contralínea. Escúchanos en Spotify, Apple Podcast e Ivoox como Contralínea Audio.
From Season 3 – For training that will get you to the next level, heed the advice of expert Lynn Walder on everything from the importance of self-awareness and systems thinking to networking to upskilling outside of your comfort zone. Recorded at EA Ignite Spring 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.
It Happened To Me: A Rare Disease and Medical Challenges Podcast
Infertility can affect nearly every part of a person's life, from their emotional well-being and relationships to their finances, identity, and sense of control over the future. After spending six years trying to conceive, navigating complex fertility treatments, and paying more than $100,000 out of pocket, Jessica Chalk understood firsthand how exhausting and isolating the fertility journey can become. Along with the physical demands of treatment, patients are often expected to coordinate appointments, track medical information, make complicated decisions, and advocate for themselves while coping with grief and uncertainty. In this episode of It Happened To Me, Jessica joins hosts Beth Glassman and Cathy Gildenhorn for an honest conversation about the realities of infertility that are often hidden from view. She shares the emotional and financial weight of her experience, the impact it had on her identity and relationships, and what helped her continue through six difficult years. Jessica also explains how feeling unsupported within the healthcare system ultimately inspired her to found myStoria and advocate for a more coordinated, compassionate approach to patient care. In This Episode, We Discuss The beginning of Jessica's six-year journey to conceive Realizing that becoming pregnant would be more complicated than expected The isolation, grief, and uncertainty associated with infertility What fertility treatments demand from patients physically and emotionally Spending more than $100,000 out of pocket on treatment How financial pressure intensified an already stressful experience Feeling unseen and overwhelmed while navigating the healthcare system The effects of infertility on identity, body image, and self-worth How fertility struggles can affect partners, family members, and friendships Hurtful comments and common misconceptions about infertility Protecting your mental health during prolonged treatment What helped Jessica continue during the most difficult moments The support she wishes she had received earlier What people who have not experienced infertility often misunderstand The emotional turning point that inspired Jessica to create myStoria How her experience changed her understanding of patient-centered care Jessica's message for anyone currently struggling to build a family About Jessica Chalk Jessica Chalk is the founder and CEO of myStoria, a patient-support platform created to help people organize medical information, prepare for appointments, coordinate care, and navigate complex reproductive health journeys. Jessica's work was inspired by her own six-year fertility journey, during which she experienced the emotional, financial, and logistical burden frequently placed on patients. She founded myStoria with the goal of ensuring that people facing complicated medical situations do not have to manage every aspect of their care alone. Infertility Support and Educational Resources myStoria: Patient navigation and organizational support for reproductive health and other complex medical journeys RESOLVE: The National Infertility Association: Education, peer-led support groups, advocacy resources, and information for people experiencing infertility ReproductiveFacts.org: Patient-friendly information from the American Society for Reproductive Medicine about infertility, reproductive health, testing, and treatment options A Note for Our Listeners Terminology update: During this episode, we use the term polycystic ovary syndrome (PCOS). Since the episode was recorded, the condition has been renamed polyendocrine metabolic ovarian syndrome (PMOS). The updated name is intended to better represent the condition's wide-ranging hormonal, metabolic, and reproductive effects rather than suggesting that it is defined primarily by ovarian cysts. Infertility can involve grief, pregnancy loss, financial hardship, medical trauma, and difficult decisions about family building. Please take care of yourself while engaging with this episode and seek support from a qualified healthcare or mental health professional when needed. The experiences discussed in this episode reflect Jessica's personal journey and are not intended as individualized medical advice. Treatment options, outcomes, costs, and insurance coverage vary considerably. Speak with your healthcare team about questions related to your own fertility or reproductive health. Connect With It Happened To Me Podcast Stay tuned for the next episode of It Happened To Me. In the meantime, explore our previous episodes on Spotify, Apple Podcasts, YouTube, ItHappenedToMe.com, or your favorite podcast platform by searching for It Happened To Me. It Happened To Me is created and hosted by Cathy Gildenhorn and Beth Glassman. Kira Dineen of Gene Pool Media serves as Executive Producer. For questions, guest suggestions, or other inquiries, contact us at ItHappenedToMePod@gmail.com.
"Doc, do I need to take this forever?" It's one of the most common questions I hear in my office, whether it's someone's very first visit or someone who's already lost 30, 40, even 80 pounds and is feeling great. In this episode, I break down why your body fights so hard to regain weight after you lose it, and why that's biology, not failure. I walk through the new ATTAIN Maintain trial, a study of 376 adults who had already lost significant weight on tirzepatide or semaglutide, testing whether switching to an easier once-daily oral GLP-1 could help them keep the weight off, instead of just asking whether stopping medication causes regain. Maintenance isn't about staying on one medication forever. It's about having an individualized, active plan, and the ATTAIN Maintain data gives us more options than ever to build one. Episode Highlights: Why your metabolism and hunger hormones fight to reverse weight loss Lessons from the SURMOUNT-4 trial on what happens when treatment stops completely Inside the ATTAIN Maintain trial design and who was studied The weight maintenance results: oral medication vs. placebo Why maintenance therapy doesn't have to look like the treatment that got you there What actually goes into a sustainable long-term plan beyond medication Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of industry-shaping events, reflecting the ever-evolving landscape of drug development, regulatory challenges, and strategic maneuvers. In a significant move within the sector, Jasper Therapeutics has merged with Kira Pharmaceuticals, a strategic decision aimed at expanding its footprint in autoimmune therapeutics. This merger brings to Jasper a valuable asset in KP-104, a dual-inhibitor with the potential to address rare diseases—an area of considerable unmet need. Such consolidations highlight an industry trend where companies seek to bolster their portfolios with promising candidates that can tackle complex medical conditions. The merger exemplifies how strategic expansions are becoming increasingly integral to maintaining competitive edges in the biotech arena. Turning to clinical trials, Takeda's Zasocitinib has demonstrated promising results for patients suffering from moderate-to-severe plaque psoriasis. In Phase 3 trials, a significant 75% of patients achieved clearance of scalp psoriasis. Zasocitinib operates as a TYK2 inhibitor, targeting the IL-23 pathway—a crucial mechanism in autoimmune diseases like psoriasis. This breakthrough promises to enhance patient care by providing a more effective treatment option for those struggling with difficult-to-treat psoriasis. On the regulatory front, Novartis' Fabhalta (Iptacopan) has gained FDA approval for its role in slowing kidney function decline in patients with primary immunoglobulin A nephropathy. As a small molecule complement inhibitor, Iptacopan introduces a novel treatment class for this autoimmune kidney disorder. This approval underscores ongoing innovation within nephrology and offers renewed hope for improved patient outcomes. Recent regulatory updates also saw Novartis securing full FDA approval for Fabhalta—an affirmation of progress in addressing immunoglobulin A nephropathy through innovative therapeutic options. Business development remains a driving force in shaping industry landscapes. The acquisition of Mission Therapeutics' AKI candidate MTX652 by Dimerix is a prime example. This $5 million deal, with potential milestones up to $292 million, reflects high stakes and ambitions to advance treatments for acute kidney injuries—a field with significant unmet medical needs. The integration of artificial intelligence continues to revolutionize drug discovery processes. Aqemia's collaboration with Sanofi highlights this trend, showcasing AI's crucial role in expediting drug development and uncovering novel therapeutic targets. Their partnership potentially worth $140 million underscores AI's transformative potential within pharmaceutical research. Notably, Nobel laureate Jennifer Doudna's foray into AI-powered protein design signifies an exciting intersection between gene-editing technology and artificial intelligence. Her involvement signals potential revolutions in drug discovery through enhanced precision in protein engineering. However, regulatory challenges persistently loom over the industry. Novo Nordisk and Alvotech have faced FDA scrutiny concerning manufacturing deficiencies—an issue that accentuates the importance of stringent quality control and operational excellence in biologics manufacturing. The American Society of Health-System Pharmacists (ASHP) report on U.S. drug shortages during Q2 2026 reveals vulnerabilities within supply chains, notably impacting oncology drugs. These shortages emphasize the critical need for robust strategies to ensure consistent drug availability for essential therapies. Furthermore, geopolitical dynamics are influencing pharmaceutical supply chains. A U.S. Senate bill aimed at increasing transparency highlights concerns over China's dominance in drug ingredient supplies—an issue necessitating strategic adjustments by globally operating companies. Elsewhere within the sector, GSK made headlines by discontinuing the development of its chronic cough treatment camlipixant following mixed Phase 3 trial results—a setback illustrating the critical nature of trial outcomes in determining drug viability and market potential. In market trends, biotech IPOs have surged during the first half of 2026—a sign of robust investor interest fueled by innovations and favorable funding environments despite associated market volatility risks. Strategic adjustments continue across companies with mergers and acquisitions leading to workforce reductions—projected layoffs exceeding 14,000 within biopharma during H1 2026—as organizations streamline operations or pivot towards more promising research domains. Lastly, Merck's FDA approval for an oral PCSK9 inhibitor marks a significant achievement in cardiovascular care—representing another stride forward in therapeutic innovation. In summary, these developments encapsulate a landscape defined by scientific pursuits yielding mixed results amidst evolving regulatory interactions and strategic realignments—all contributing towards innovative healthcare solutions while navigating complex industry dynamics.Support the show
In this episode of the DermSurgery Digest, you'll hear quick, high-yield summaries with practical takeaways on the cosmetic and general dermatology articles featured in the July 2026 issue of Dermatologic Surgery. Featured contributors this month are Ardalan Minokadeh, MD, PhD, and Kristel Polder, MD.This podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining cosmetic and general dermatology articles from the July issue are highlighted in-depth in a companion episode, Spotlight, published on July 10, 2026.We welcome your feedback. Please contact communicationstaff@asds.net.
In this episode of the DermSurgery Digest, you'll hear quick, high-yield summaries with practical takeaways on the surgical oncology and reconstruction articles featured in the July 2026 issue of Dermatologic Surgery. Featured contributors this month are Kyle Lauck, MD, and Ally-Khan Somani, MD, PhD, EMBA.This podcast is hosted by Naomi Lawrence, MD, Digital Content Editor for Dermatologic Surgery, and co-hosted by Michael Renzi, MD. Dermatologic Surgery is the official publication of the American Society for Dermatologic Surgery.The remaining surgical oncology and reconstruction articles from the July issue are highlighted in-depth in a companion episode, Spotlight, published on July 10, 2026.We welcome your feedback. Please contact communicationstaff@asds.net.
"Lethal and sublethal effects of novaluron, a novel insect growth regulator, on annual bluegrass weevil, Listronotus maculicollis Kirby, lifestages in turfgrass" with Benjamin A McGraw. Today we'll be talking to Dr. Benjamin McGraw. Annual bluegrass weevil or ABW is a pest that preys on golf course turf. Novaluron is a new pesticide that may be able to help control ABW, but how does it work and at which life stages is it most effective? In this episode, Benjamin joins me to discuss his work studying novaluron. If you would like more information about this topic, this episode's paper is available here: https://doi.org/10.1002/csc2.70042 This paper is always freely available. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to Ben, you can find him here: bam53@psu.edu Resources Penn State Turf: https://plantscience.psu.edu/research/centers/turf Penn State Turf X: https://x.com/psuplantscience Penn State Turf Instagram: https://www.instagram.com/psuplantscience/ CEU Quiz: https://web.sciencesocieties.org/Learning-Center/Courses/Course-Detail?productid=%7bBFDA7038-5981-F111-AB0E-70A8A59D1B85%7d Transcripts: Coming soon Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.
In a special crossover episode, The Splice Girls Podcast joins Between the Lines with FGI for a conversation that connects the intent behind health care facility requirements with the realities of construction and implementation. Drawing on FGI's authority in health care facility planning and design, Between the Lines with FGI explores the purpose and intent behind the minimum requirements that shape safe, functional, and resilient environments of care. The Splice Girls Podcast brings the perspective of the field, creating space for authentic conversations about the challenges and opportunities facing today's construction industry. Sponsored by: American Society for Health Care Engineering (ASHE): Optimizing health care facilities Link to show notes: https://fgiguidelines.org/podcast/s3-e5-between-the-lines-with-fgi-and-the-splice-girls-podcast-how-collaboration-shapes-the-fgi-codes/
Greg Watkins-Colwell is Senior Collection Manager of Herpetology and Ichthyology at the Yale Peabody Museum, where his work spans natural history collections, systematics, biogeography, research, and public education. He also serves on the Board of Governors of the American Society of Ichthyologists and Herpetologists and the Science Advisory Board of Connecticut's Beardsley Zoo.
In this episode, reproductive mental health expert Dr. Mary Riddle joins us to explore the psychological dimensions of infertility, new parenthood, and donor conception — drawing on both clinical expertise and her own fertility journey. Dr. Riddle reframes infertility as a genuine psychological crisis, not just a medical one and discusses reasons for dropping out of treatment. She further discusses how partners often grieve differently, and assuming otherwise creates distance. After finally conceiving, parents may face anxious pregnancies and guilt around normal feelings of ambivalence — all of which Dr. Riddle urges parents to normalize and voice. On postpartum mental health, she covers both depression and the under-recognized postpartum anxiety (affecting 11–21% of new mothers), encouraging parents not to let cultural pressure to appear blissful delay seeking help. Finally, Dr. Riddle advocates for early, open conversations with donor-conceived children. Resources Seleni Institute (seleni.org) — therapy, support groups, and educational resources for individuals and families navigating infertility, postpartum mental health, and all stages of the family-building journey American Society for Reproductive Medicine (asrm.org) — mental health provider finder and patient resources maryriddle.com — Dr. Riddle's research and practice information (coming soon)
Jonathan Villena-Vargas, MD, sits down with Erin Gillaspie, MD, to examine key findings from the American Society of Clinical Oncology (ASCO) Annual Meeting, including advances in targeted therapy, dual-pathway immunotherapy, artificial intelligence, and adaptive treatment strategies that are reshaping thoracic oncology.
Cancer has long been associated with aging, but in recent years, doctors have seen an alarming rise in colorectal cancer and other cancers among younger adults. In this episode of Health Matters, host Courtney Allison speaks with Dr. Dorna Jafari, chief of colorectal surgery at NewYork-Presbyterian Brooklyn Methodist Hospital, about what may be contributing to this growing public health concern. Dr. Jafari explains that colorectal cancer is now the leading cause of cancer death in people under age 50 and discusses the "birth cohort effect" researchers have identified among people born after 1960. She explores several factors that may be influencing cancer risk, including changes in diet, increased consumption of ultra-processed foods, disruptions to the gut microbiome, antibiotic exposure, and the growing presence of microplastics in the environment. The conversation also focuses on prevention. Dr. Jafari shares practical steps people can take to support a healthy microbiome and reduce cancer risk, including increasing fiber intake, staying physically active, limiting sugary beverages, and making realistic lifestyle changes over time. Finally, she discusses the exciting advances changing the future of oncology. From targeted cancer therapies and immunotherapy to AI-assisted diagnosis and improved screening tools, Dr. Jafari explains why cancer outcomes continue to improve and why early detection remains one of the most powerful tools available—especially when it comes to colorectal cancer screening. Chapters 00:00 – Why Are More Young People Getting Cancer? Understanding the rise of early-onset cancers and why colorectal cancer rates are increasing in adults under 50 03:15 – Diet, Microbiome, and Environmental Risks How ultra-processed foods, sugary drinks, antibiotics, and microplastics may influence cancer risk 07:20 – New Advances in Cancer Treatment The shift toward targeted therapies, immunotherapy, AI, and personalized cancer care 10:15 – Screening, Prevention, and Living Healthier Why colonoscopies remain the gold standard and the lifestyle habits that can help lower risk Key Topics Covered Early-onset colorectal cancer Rising cancer rates in young adults Colorectal cancer mortality trends Ultra-processed foods and cancer risk Sugar-sweetened beverages Gut microbiome health Antibiotic exposure and cancer Microplastics and potential health effects Fiber and digestive health Cancer prevention strategies Targeted cancer therapies Immunotherapy Artificial intelligence in oncology Colonoscopy screening Blood-based cancer screening tests Fertility preservation during cancer treatment Holistic cancer care Cancer survivorship and outcomes Key Takeaway While cancer is increasingly affecting younger adults, there are meaningful steps people can take to reduce their risk. Prioritizing screening, maintaining a healthy diet rich in fiber, limiting ultra-processed foods and sugary drinks, staying active, and paying attention to symptoms can make a difference. At the same time, advances in targeted therapies, immunotherapy, and AI-driven diagnostics are helping improve outcomes and offering new hope for the future of cancer care. Doctor Bio Dr. Mehraneh Dorna Jafari is chief of colorectal surgery at NewYork-Presbyterian Brooklyn Methodist Hospital and associate professor of surgery at Weill Cornell Medicine. She is the director of clinical research in the department of surgery at NewYork-Presbyterian/Weill Cornell Medical Center. She is board-certified in general surgery and colon and rectal surgery. Dr. Jafari specializes in the comprehensive care of colorectal cancer patients, patients with peritoneal surface disease as well as those patients with benign colorectal disease. Dr Jafari works with a world-renowned group of multidisciplinary specialists to help promote a patient centered treatment plan for her patients, including radiation oncologists, medical oncologists, radiologists, pathologists, gastroenterologists, and interventional radiologists. Her goal is to provide precision medicine to patients that is safe and effective. Dr. Jafari has expertise in minimal access techniques, including laparoscopic, and robotic surgery. In addition, she has special interests in sphincter preserving surgery (helping rectal cancer patients avoid a permanent ostomy), maintaining fertility in cancer patients, and improving quality of life and bowel function after rectal surgery. Dr Jafari has been at forefront of research with regards to improving outcomes using enhanced recovery and narcotic sparing protocols. Dr. Jafari is among a small number of surgeons who offers surgery for metastatic colon, appendiceal and peritoneal surface disease. She utilizes cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), which involves heated chemotherapy applied directly within the abdominal cavity following removal of cancerous tumors. Dr. Jafari's clinical research focuses on quality of life and oncological outcomes for colorectal cancer patients. Her main area of expertise is starting chemotherapy earlier in cancer treatment to allow patients to recover their quality of life sooner. Dr. Jafari has written extensively and published in many major journals, including the Journal of the American Medical Association (JAMA), Annals of Surgery, and the Journal of the American College of Surgeons. She has led numerable courses teaching surgeons around the country how to perform minimal invasive surgery. Dr. Jafari is actively involved in many national surgical and oncologic societies, including the American College of Surgeons, Society of Surgical Oncologists, American Society of Colon and Rectal Surgeons and Association of Women Surgeons.
Highlights from the PER® CME activity "Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2− Metastatic Breast Cancer–What the Latest Data Really Tell Us" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.In this podcast, experts Virginia Kaklamani, MD, DSc; Kamel Abou Hussein, MD; Javier Cortés, MD, PhD; and Seth A. Wander, MD, PhD, discuss American Society of Clinical Oncology (ASCO) 2026 updates about data for oral selective estrogen receptor degraders (SERDs) to treat metastatic, HR-positive breast cancer.Earn CME credit by completing the full accredited activity (available through June 29, 2027): https://www.gotoper.com/courses/oncology-town-hall-updates-from-chicago-oral-serds-in-hrher2-metastatic-breast-cancerwhat-the-latest-data-really-tell-us This podcast, including the narration, was developed by PER® (Physicians' Education Resource®, LLC) editorial staff from the full online CME activity developed with these faculty. The narration was voiced by a PER staff member or by an AI tool. The podcast contains no product advertising. The full activity is supported by an educational grant from Stemline Therapeutics, Inc.This content is for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Faculty may discuss investigational or off-label uses; consult prescribing information for any products discussed.
What happens behind the sealed doors of a biocontainment laboratory when a patient with a suspected special pathogen—like Ebola or Lassa fever—arrives at a hospital? In this episode of Transmission Interrupted, host Jill Morgan is joined by Vicki Herrera, biocontainment laboratory training and education leader at UNMC, and Colleen Kraft, medical and laboratory director of Emory's Biocontainment Unit. Together, they break down the critical question: what are “basic labs,” and how can frontline healthcare facilities prepare to deliver essential diagnostics safely during a special pathogen event?Listen in as Jill, Vicki, and Colleen demystify the realities of emergency lab testing, exploring the tension between the rapid results clinicians want and the vital safety measures laboratorians must uphold. They discuss point-of-care devices, the nuances of risk assessments, and the keys to interdepartmental communication that ensure both effective patient care and laboratory safety. Whether you're a bedside nurse, an ED provider, or a laboratorian, this candid, practical conversation will help you understand how healthcare teams can work together to deliver safe and swift care—even in the face of emerging infectious threats.Questions or comments for NETEC? Contact us at info@netec.org.Visit Transmission Interrupted on the web at netec.org/podcast.GuestsVicki Herrera, MS Research Coordinator University of Nebraska Medical Center Vicki Hererra is a Research Coordinator at the University of Nebraska Medical Center in the field of infectious diseases and bioaerosols. She has supported the Nebraska Biocontainment Unit for the past 16 years and currently supports both NETEC and the Nebraska Biocontainment Unit Laboratory by providing education and training to laboratory staff. She is also a co-lead of NETEC's Laboratory Working Group. Colleen S. Kraft, MD, MSc Professor, Department of Pathology and Laboratory Medicine Professor, Infectious Diseases, Department of Medicine Emory University School of Medicine Colleen S. Kraft, MD, MSc, is a Professor in the Department of Pathology and Laboratory Medicine as well as a Professor in the Department of Medicine Division of Infectious Diseases at Emory University School of Medicine. Dr. Kraft was the Associate Chief Medical Officer of Emory Hospital from 2020-2023 and is currently the Associate Chief Research Informatics Officer for the Woodruff Health Sciences Center. Dr. Kraft served as the President-Elect, President and Past President of the American Society for Microbiology from 2021-2024. Dr. Kraft was one of the infectious disease physicians at Emory Hospital in 2014 to receive and care for patients who had contracted Ebola virus disease and Lassa fever in West Africa. Dr. Kraft is a clinical consultant for the Emory Healthcare Human Factors Lab, and a director in the Healthcare Test Kitchen Lab, both of which were in response to the desire for high reliability after the care of patients with highly contagious infectious diseases. HostJill Morgan, RNEmory Healthcare, Atlanta, GAJill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI)ResourcesNETEC - Lab ResourcesNETEC - Resource LibraryNETEC - Transmission Interrupted PodcastAbout NETECA Partnership for PreparednessThe National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.For more information, visit NETEC on the web.NETEC Consultation ServicesAssess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting.NETEC offers free virtual and on-site readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert.For more information, visit NETEC Consulting Services.
What if you could do a beautiful class four in the same 30 minutes you'd spend on a regular filling? In this episode, Dr. Reza Ardalan sits down with Dr. Susan McMahon, an AACD-accredited restorative dentist out of Pittsburgh and one of the most recognized clinicians in the country. Susan is the founder of Smiles in the City, a fee-for-service restorative practice she built from the ground up after starting her career in a drill-fill-and-bill amalgam office. The conversation takes a personal turn early when Susan tells the story of the $100,000 laser whitening system she signed up for without reading the contract — the moment her practice tipped from "what people need" to "what people want." From there, Reza and Susan go everywhere: why AACD accreditation rebuilds your eye, how she became a restorative referral source for teenagers and post-ortho cases, the conservative European mindset she picked up training in Italy, why diastema closure and class four restorations can be done predictably in the same time as a regular filling, and the tag-the-practice social media system that fills her chair. A key part of the conversation lands at the end. Susan walks Reza through her upcoming online restorative course — five one-hour modules built for general dentists who want to elevate their everyday restorations without slowing down their day. Module one is the class four. Module two is the invisible class three (no gray, no lost sheen). Module three is her five-minute finish — the polish that puts surface anatomy back so composite reads as enamel instead of plastic. Module four is using provisionals as the prototype for final restorations. Module five covers her full enamel treatment toolkit — microabrasion, infiltration, whitening combinations. It's the first time she's put her actual restorative system online, and if you've ever felt the gap between what you see on social media and what you can actually produce in your operatory, this one is gold. Key Points The $100,000 laser whitening machine she signed for without reading the contract — and why it changed her career Why a beautiful class four takes the same 30 minutes as a regular class four — if you know the system The invisible class three: how to finish without gray shadow or lost sheen Using provisionals as the prototype for final restorations — the move most GPs skip The full enamel treatment toolkit: microabrasion, infiltration, and whitening combinations Why AACD accreditation is closer to a board exam than a CE certificate How she became a restorative referral source for teenagers coming out of ortho Why 40% of clear orthodontic cases finish with black triangles What four trips to Italy taught her about being conservative with the drill Dr. Susan McMahon is a clinician and educator whose teaching focuses on conservative techniques that preserve natural tooth structure. She lectures internationally on minimally invasive cosmetic and restorative work, sharing the techniques she uses in her own practice with general dentists worldwide. As an Accredited Member of the American Academy of Cosmetic Dentistry, Fellow of the American Society for Dental Aesthetics, and Fellow of the Academy of General Dentistry, Dr. McMahon leads one of Western Pennsylvania's premier cosmetic dental practices. She has been named a Top Dentist more than 20 times, including consecutive annual selections as a Top Pittsburgh Dentist by her peers for more than two decades. Find Dr. McMahon on Instagram at @smilesinthecity and @DrSusanMcMahon. Learn more about Zero Trace Restoration on Dental Education Studios. Five techniques that make everyday restorations look like advanced esthetic dentistry — built around systems any general dentist can run in their existing appointment blocks. The course starts on Tuesday, Sept. 15th. Join live or watch the on-demand recordings.
In our July episode, we went beyond the headlines to get the facts about GLP-1 medications with Dr. Holly Lofton, Director of the Medical Weight Management Program at NYU Langone. In this month's Key Note episode, Dr. Lofton explains how the new oral GLP-1 medications compare with injections and shares important information that can help patients make informed decisions about their care. The Takeaway We want to hear from you! Please complete our survey: www.1199SEIUBenefits.org/member-feedback. Drop us a line at our social media channels: Facebook // Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers: www.1199SEIUBenefits.org/healthyrelationships. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Relieve stress with mindfulness classes at www.1199SEIUBenefits.org/healthyminds. Find healthy recipes and meal-prep tips at www.1199SEIUBenefits.org/food-as-medicine. Visit the Healthy Living Resource Center for wellness tips, information and resources: www.1199SEIUBenefits.org/healthyliving. Get inspired by fellow members through our Members' Voices series: www.1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: www.1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: www.youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: www.1199SEIUBenefits.org/wellnessevents. Guest Bio Holly F. Lofton, MD, is a Clinical Associate Professor of Medicine and Surgery at NYU Langone Health, where she has served as director of the Medical Weight Management Program since 2012. Here, she designed the popular New You program to help her patients obtain results while fostering nutrition education and placing emphasis on a healthy lifestyle. She is currently involved in clinical research pertaining to the pharmacotherapy to treat weight recurrence after bariatric surgery as well as clinical drug trials. In her faculty role, Dr. Lofton continues to educate students and other physicians about diagnosing and treating obesity. She also educates the general public about the importance of maintaining a healthy weight through lectures, workshops, and written, audio and video media. She has served on the board of the Obesity Action Coalition, the Bariatric Medicine committee for the American Society for Metabolic and Bariatric Surgery, and the Obesity Medicine Fellowship Council. In 2021, Dr. Lofton was also appointed as the Medical Director of the NFL Alumni Wellness Challenge, which aims to optimize health in former athletes.
We welcome back John Horvat II of the American Society for the Defense of Tradition, Family and Property to examine the meaning of proclaiming "Christ is King" in an increasingly secular culture. What changes when Christ's authority is no longer recognized in public life or even within the Church? Father finishes with Timely Thoughts. Show Notes Christ is King, No Matter Who says It or Not Why Modern Law Clashes with the Social Kingship of Our Lord Jesus Christ Quas Primas iCatholic Mobile The Station of the Cross Merchandise - Use Coupon Code 14STATIONS for 10% off | Catholic to the Max Read Fr. McTeigue's Written Works! "Let's Take A Closer Look" with Fr. Robert McTeigue, S.J. | Full Series Playlist Listen to Fr. McTeigue's Preaching! | Herald of the Gospel Sermons Podcast on Spotify Visit Fr. McTeigue's Website | Herald of the Gospel Questions? Comments? Feedback? Ask Father!
The fertilization report looked good. You had eggs. They fertilized. Day three looked fine. Then came the call. Nothing made it past day five, or one did, and it was graded poor, and the cycle was over. You were told it was egg quality, or it was a numbers game, or that you have to try again. Here is what that explanation leaves out. An embryo does not run on one engine the whole way. For the first two to three days it runs almost entirely on the egg, on the proteins, the messenger molecules, and the energy the egg packed during its final growth phase. Then, around the four to eight cell stage on day three, the embryo activates its own genome and takes over, and the paternal contribution comes online. That handover changes where you look. If development stalls in the first three days, you start with the egg and its energy supply. If it looked strong on day three and stalled before the blastocyst, you start with the sperm and its DNA. Same line in the report. Two completely different first moves. Most workups examine neither. They adjust the protocol and go again. In this episode, I walk through the seven factors that shape whether an embryo keeps dividing, and what most clinics never review before they tell you it was your eggs. Pull it up, take notes, and bring it to your next appointment. TIMESTAMPS 00:00 The day five call and what the explanation leaves out 00:55 If this show has helped you, leave a review 01:05 Who reviews your case at Fab Fertile 03:50 Number one: the day three handover and where to look first 06:10 Number two: the egg's energy supply was built before the cycle 08:05 Number three: sperm DNA fragmentation and the standard semen analysis 09:20 Number four: the full thyroid panel, including antibodies 10:20 The Embryo Audit Checklist 10:40 Number five: blood sugar and insulin, for both of you 11:45 Number six: inflammation, the gut microbiome, oxidative stress 12:40 Number seven: the ninety day window and why repeating a cycle repeats the result 13:45 Why the data driven approach works for left brain people 14:30 Chromosomal quality is information, not a verdict 14:55 The Functional Fertility Second Opinion WHAT THE RESEARCH SHOWS A standard semen analysis measures count, motility, and shape. It does not measure the integrity of the DNA inside the sperm. Sperm carrying damaged DNA can still fertilize an egg and produce a normal-looking embryo on day two or three, and development can stall after the genome handover. In a 2025 retrospective analysis of 870 fresh single blastocyst ICSI cycles, each one percent increase in sperm DNA fragmentation was associated with roughly 2.5 percent lower odds of obtaining a top quality blastocyst on day five. The same analysis found that fragmentation was not predictive of clinical pregnancy outcomes. It speaks to why an embryo stalled, not to whether a pregnancy will happen. Thyroid autoantibodies have been detected in follicular fluid at concentrations that correlate with blood levels, which is one reason a complete thyroid panel may include Free T3, Free T4, Reverse T3, TPO antibodies, and thyroglobulin antibodies rather than TSH alone. These are not established diagnostic tests for embryo arrest. They can provide context that a single TSH result cannot. THE EMBRYO AUDIT CHECKLIST If your embryos have arrested and you want to walk through what to review before the next cycle repeats the same result, we built the Embryo Audit Checklist for exactly this. Download it at https://fabfertile.com/pages/embryo-audit-checklist Or email hello@fabfertile.ca, subject line CHECKLIST. FUNCTIONAL FERTILITY SECOND OPINION This is a call where I review your cycle, your labs, your history, and your partner's picture together in one place. You leave knowing what your embryos may be telling you and what the next cycle would be built on, instead of repeating the same outcome. Whatever you decide afterward is yours, but it gets made with information your workup did not give you. Book at https://fabfertile.com/pages/book Or email hello@fabfertile.ca, subject line FERTILE. ABOUT THE HOST I'm Sarah Clark, founder of Fab Fertile and host of Get Pregnant Naturally, a podcast with over one million downloads. My functional fertility team works with couples navigating low AMH and failed IVF, reviewing functional lab results, gut microbiome, food sensitivity, vaginal microbiome, nutrigenomics, HTMA, DUTCH, toxin testing, and bloodwork alongside nervous system work, to help identify patterns that may not have been considered. We work alongside your medical team, not instead of them. Subscribe to Get Pregnant Naturally for weekly episodes on fertility optimization, IVF preparation, and the lab work your doctor probably isn't running. Sarah Clark, founder of Fab Fertile, host of Get Pregnant Naturally (1M+ downloads), and author of Fabulously Fertile. If this episode helped you make sense of your own numbers, leave a review wherever you listen. It is how another woman, being told the same thing, finds her way here. REFERENCES Machałowski T, Machałowska J, Gill K, et al. Sperm DNA Fragmentation Impairs Early Embryo Development but Is Not Predictive of Pregnancy Outcomes: Insights from 870 ICSI Cycles. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167923 Monteleone P, Parrini D, Faviana P, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. American Journal of Reproductive Immunology. 2011. American Urological Association and American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. 2020.
If you've seen headlines linking Ozempic and other GLP-1 medications to sudden eye strokes, I want to stop the panic right here. In this episode, I break down what the research on NAION actually shows, who's really at risk, and why the scary relative-risk numbers you're seeing online don't tell the whole story. I walk you through what NAION is, why patients on semaglutide often already carry the underlying risk factors that get left out of the clickbait, and what the difference is between an observational study raising a signal and a randomized trial proving cause and effect. I also share the warning signs that mean you should go to the ER immediately, not wait for your next appointment. You'll walk away knowing exactly how to think about this headline, what questions to bring to your own doctor, and why staying on your medication is usually the right call. Episode Highlights: What NAION is and how it affects the optic nerve The risk factors patients on GLP-1s often already have What the 37-million-person study actually found — and didn't Why randomized trials tell a different story than observational data Absolute risk vs. relative risk, explained simply Warning signs that mean go to the ER now Why sleep apnea complicates the whole picture Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH. Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014. In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss, where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, "Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''. Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)
What if one of the most powerful tools to help cancer patients wasn't another medication—but movement?In this episode of The Breast Cancer Podcast, Dr. Mark Cripe and I sit down with one of the world's leading pioneers in Exercise Oncology, Dr. Jay Harness, to discuss why exercise is becoming an essential part of cancer care.We explore:
From Season 3 – Looking for time management strategies as an executive assistant or administrative professional? Learn from Harvard Business School professor Ashley Whillans to more effectively find, fund, and reframe your time. Recorded at EA Ignite Spring 2024 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.
Dr. Martha Muñoz is an Assistant Professor in the Department of Ecology and Evolutionary Biology at Yale University. Martha is an evolutionary biologist who is working to better understand how and why evolution proceeds unevenly across the tree of life. Some features and branches of organisms evolve really quickly, while others remain inert or nearly inert for millions of years. Martha's research is uncovering the mechanisms underlying this phenomenon, and she has discovered that behavior is a key architect of evolution. For Martha, nature is a wonderful source of peace and inspiration for her research. When she's not working, she enjoys exploring the outdoors, hiking, seeing amazing views, and observing wildlife. She also spends her free time reading, going to museums, and visiting her family in New York City. She received her B.A. in biology from Boston University. Afterwards, Martha worked as a Fulbright Research Scholar at the National Museum of Natural Sciences in Madrid, Spain. She was awarded her Ph.D. in Organismic & Evolutionary Biology from Harvard University. Next, Martha conducted postdoctoral research in the Research School of Biology at The Australian National University and subsequently the Department of Biology at Duke University. Prior to accepting her current position at Yale University, Martha served on the faculty in the Department of Biological Sciences at Virginia Tech. Martha has received numerous awards and honors, including the Boston University Department of Biology's Distinguished Alumni 'Rising Star' Award, and a Young Investigator Award from the American Society of Naturalists. She was also named a 'Scientist to Watch' by The Scientist Magazine in 2019. In our interview, Martha shares more about her life and science.
The violence that spread across Harlem on the night of March 19, 1935 was the first large-scale racial disorder in the United States in more than a decade and the first occurrence in the nation's leading Black neighborhood. However, as many observers pointed out, the events were “not a race riot” of the kind that had marked the decades after the Civil War. Racial violence took a new form in 1935. Through a granular analysis of those events and the mapping of their locations, Harlem in Disorder: A Spatial History of How Racial Violence Changed in 1935 (Stanford University Press, 2024) reveals that Harlem's residents participated in a complex new mix of violence that was a multifaceted challenge to white economic and political power. Tracing the legal and government investigations that followed, this project highlights how that violence came to be distorted, diminished, and marginalized by the concern of white authorities to maintain the racial order, and by the unwillingness of Harlem's Black leaders and their white allies to embrace fully such direct forms of protest. Focused on capturing rather than simplifying the complexity of the new form of racial violence, Harlem in Disorder is a multi-layered, hyperlinked narrative that connects different scales of analysis: individual events, aggregated patterns, and a chronological narrative. Its structure foregrounds individual events to counter how data can dehumanize the past, and to make transparent the interpretations involved in the creation of data from uncertain and ambiguous sources. Harlem in Disorder is an award-winning monograph earning recognition as a Finalist for the 2026 ACLS Open Access Book Prize, Multimodal Category, sponsored by the American Council of Learned Societies; winner of the 2025 Ángel David Nieves Book Award for Best Monograph, sponsored by the American Studies Association Digital Humanities Caucus; Honorable Mention for the 2025 Mary L. Dudziak Digital Legal History Prize, sponsored by the American Society for Legal History, and Honorable Mention for the 2025 Open Scholarship Award, sponsored by the Canadian Social Knowledge Institute. Kishauna Soljour is an Assistant Professor of Public Humanities at San Diego State University. Her most recent writing appears in the edited collection: From Rights to Lives: The Evolution of the Black Freedom Struggle. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/african-american-studies
© 2020-2026 Ivy Podcast Discovery LLC
